- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge upgrades PACS software
PACS developer Merge eFilm has enhanced its Fusion PACS to provide referring physicians with improved Web-based accessibility and image manipulation capabilities. The company's Fusion PACS version 1.2.7 provides secure access to images and reports via
PACS developer Merge eFilm has enhanced its Fusion PACS to provide referring physicians with improved Web-based accessibility and image manipulation capabilities. The company's Fusion PACS version 1.2.7 provides secure access to images and reports via the Web, and allows them to be viewed with a set of image manipulation tools similar to those in the eFilm Workstation software, which is optimized for use by radiologists. These additional tools allow the measurement of tumors and analysis of fractures. The upgrade also includes an enhanced security filtering capability that enables operators to manage multiple varied levels of access restrictions by referring physicians. An Image Viewer Plug-in permits third parties to embed image and report viewing capabilities into their own solutions.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
